Genetic and Physiological Effects of Insulin-Like Growth Factor-1 (IGF-1) on Human Urate Homeostasis
暂无分享,去创建一个
T. Merriman | Hyon K. Choi | D. Mount | M. Leask | A. Mandal | N. Sumpter
[1] T. Merriman,et al. Genetic and Physiological Effects of Insulin on Human Urate Homeostasis , 2021, Frontiers in Physiology.
[2] B. Ban,et al. Association Between Uric Acid and Insulin-Like Growth Factor-1 in Type 2 Diabetes Mellitus , 2021, International journal of general medicine.
[3] M. Mann,et al. Distinct signaling by insulin and IGF-1 receptors and their extra- and intracellular domains , 2021, Proceedings of the National Academy of Sciences.
[4] G. You,et al. Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination. , 2020, Pharmacology & therapeutics.
[5] T. Merriman,et al. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion , 2020, Nature Communications.
[6] N. Osada,et al. Dysfunctional missense variant of OAT10/SLC22A13 decreases gout risk and serum uric acid levels , 2019, Annals of the rheumatic diseases.
[7] D. Mount,et al. Interaction Between ITM2B and GLUT9 Links Urate Transport to Neurodegenerative Disorders , 2019, Front. Physiol..
[8] Y. Okada,et al. Genomic dissection of 43 serum urate-associated loci provides multiple insights into molecular mechanisms of urate control , 2019, bioRxiv.
[9] G. You,et al. Insulin-like growth factor 1 modulates the phosphorylation, expression, and activity of organic anion transporter 3 through protein kinase A signaling pathway , 2019, Acta pharmaceutica Sinica. B.
[10] G. Sesti,et al. The polymorphism rs35767 at IGF1 locus is associated with serum urate levels , 2018, Scientific Reports.
[11] T. Merriman,et al. An update on the genetics of hyperuricaemia and gout , 2018, Nature Reviews Rheumatology.
[12] C. Duan,et al. IGF-Binding Proteins: Why Do They Exist and Why Are There So Many? , 2018, Front. Endocrinol..
[13] A. Goumenou,et al. Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters , 2017, Molecular pharmaceutics.
[14] D. Mount,et al. Uricosuric targets of tranilast , 2017, Pharmacology research & perspectives.
[15] Janina M. Jeff,et al. Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling , 2016, Clinical kidney journal.
[16] D. Mount,et al. The molecular physiology of uric acid homeostasis. , 2015, Annual review of physiology.
[17] G. Sesti,et al. Low circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[18] A. V. Rij,et al. Twenty-eight loci that influence serum urate levels: analysis of association with gout , 2014, Annals of the rheumatic diseases.
[19] A. Schürmann,et al. Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9 , 2014, Nature Communications.
[20] K. Yan,et al. Expression of SLC2A9 Isoforms in the Kidney and Their Localization in Polarized Epithelial Cells , 2014, PloS one.
[21] C. Wallace,et al. Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.
[22] Fabian J Theis,et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations , 2012, Nature Genetics.
[23] C. Cheeseman,et al. Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses. , 2012, American journal of physiology. Renal physiology.
[24] T. Nakanishi,et al. Extra-Renal Elimination of Uric Acid via Intestinal Efflux Transporter BCRP/ABCG2 , 2012, PloS one.
[25] Y. Oh. The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities , 2012, Kidney research and clinical practice.
[26] Y. Shinohara,et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia , 2012, Nature Communications.
[27] N. Shinomiya,et al. Identification of ABCG2 Dysfunction as a Major Factor Contributing to Gout , 2011, Nucleosides, nucleotides & nucleic acids.
[28] Tadashi Yamamoto,et al. Expression and localization of insulin‐like growth factor binding proteins in normal and proteinuric kidney glomeruli , 2010, Nephrology.
[29] M. Hiasa,et al. Type 1 Sodium-dependent Phosphate Transporter (SLC17A1 Protein) Is a Cl−-dependent Urate Exporter* , 2010, The Journal of Biological Chemistry.
[30] K. Geering,et al. Mouse GLUT9: evidences for a urate uniporter. , 2009, American journal of physiology. Renal physiology.
[31] E. Boerwinkle,et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout , 2009, Proceedings of the National Academy of Sciences.
[32] S. Barros,et al. Activation of Protein Kinase Cζ Increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated Transport* , 2009, Journal of Biological Chemistry.
[33] I. Hisatome,et al. Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in Humans* , 2008, Journal of Biological Chemistry.
[34] P. Elliott,et al. SLC2A9 Is a High-Capacity Urate Transporter in Humans , 2008, PLoS medicine.
[35] A. Ashworth,et al. Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy. , 2008, Human molecular genetics.
[36] F. Russel,et al. The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. , 2008, Kidney international.
[37] T. Litman,et al. Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues. , 2006, Cancer letters.
[38] J. Chang-Claude,et al. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study , 2006, British Journal of Cancer.
[39] S. Wright,et al. Involvement of tyrosine kinase and PI3K in the regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules. , 2005, American journal of physiology. Renal physiology.
[40] E. Henriksen,et al. Enhanced insulin action on glucose transport and insulin signaling in 7-day unweighted rat soleus muscle. , 2004, Journal of applied physiology.
[41] J. Kim,et al. Identification of a Novel Voltage-driven Organic Anion Transporter Present at Apical Membrane of Renal Proximal Tubule* , 2003, Journal of Biological Chemistry.
[42] Xiao‐ping Yang,et al. Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient. , 2003, American journal of physiology. Renal physiology.
[43] Hirotaka Matsuo,et al. Molecular identification of a renal urate–anion exchanger that regulates blood urate levels , 2002, Nature.
[44] C. Ward,et al. Structure and function of the type 1 insulin-like growth factor receptor , 2000, Cellular and Molecular Life Sciences CMLS.
[45] D. Leroith,et al. Insulin-Like Growth Factor I Is Essential for Postnatal Growth in Response to Growth Hormone , 1999 .
[46] K. Siddle,et al. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. , 1998, The Biochemical journal.
[47] L. Zhu,et al. Molecular cloning and characterization of Xenopus insulin-like growth factor-1 receptor: its role in mediating insulin-induced Xenopus oocyte maturation and expression during embryogenesis. , 1998, Endocrinology.
[48] R. Bigazzi,et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. , 1996, American journal of hypertension.
[49] D. Leroith,et al. The Role of the Tyrosine Kinase Domain of the Insulin-like Growth Factor-I Receptor in Intracellular Signaling, Cellular Proliferation, and Tumorigenesis (*) , 1995, The Journal of Biological Chemistry.
[50] C T Roberts,et al. Molecular and cellular aspects of the insulin-like growth factor I receptor. , 1995, Endocrine reviews.
[51] J. Tytgat,et al. Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs , 1992, Neuron.
[52] A. Shuldiner,et al. Genes encoding receptors for insulin and insulin-like growth factor I are expressed in Xenopus oocytes and embryos. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[53] M. Lane,et al. The insulin-like growth factor 1 (IGF-1) receptor is responsible for mediating the effects of insulin, IGF-1, and IGF-2 in Xenopus laevis oocytes. , 1991, The Journal of biological chemistry.
[54] E. Van Obberghen,et al. Insulin and insulin-like-growth-factor-I (IGF-I) receptors in Xenopus laevis oocytes. Comparison with insulin receptors from liver and muscle. , 1991, The Biochemical journal.
[55] E. Krebs,et al. Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[56] E. Krebs,et al. Insulin and progesterone activate a common synthetic ribosomal protein S6 peptide kinase in Xenopus oocytes , 1988, FEBS letters.
[57] C Collins,et al. Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.
[58] P. H. Seeburg,et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.
[59] Yuan Zhang,et al. Insulin-like growth factor-1 receptor-mediated inhibition of A-type K(+) current induces sensory neuronal hyperexcitability through the phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2 pathways, independently of Akt. , 2014, Endocrinology.
[60] William A. Richardson,et al. Homozygous SLC2A9 mutations cause severe renal hypouricemia. , 2010, Journal of the American Society of Nephrology : JASN.
[61] H. Saito. Pathophysiological regulation of renal SLC22A organic ion transporters in acute kidney injury: pharmacological and toxicological implications. , 2010, Pharmacology & therapeutics.
[62] William A. Richardson,et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout , 2008, Nature Genetics.
[63] H. Werner,et al. Similarities and differences between insulin and IGF-I: Structures, receptors, and signalling pathways , 2008, Archives of Physiology and Biochemistry.
[64] C. Gieger,et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects , 2008, Nature Genetics.
[65] M. Resnick,et al. Growth, immortalization, and differentiation potential of normal adult human proximal tubule cells , 2004, In Vitro Cellular & Developmental Biology - Animal.
[66] J. T. ter Maaten,et al. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. , 1997, Clinical science.
[67] E. Ferrannini,et al. Effect of insulin on uric acid excretion in humans. , 1995, The American journal of physiology.
[68] E. Renard,et al. Insulin and IGF-1 signaling in oocyte maturation. , 1994, Hormone research.
[69] M. Czech,et al. The Insulinlike Growth Factor Receptors , 1986 .
[70] M. Rechler,et al. The nature and regulation of the receptors for insulin-like growth factors. , 1985, Annual review of physiology.
[71] P. Pilch,et al. Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor I , 1983, Nature.